Upload Avatar (500 x 500)
方维佳
Medical School
浙江大学
浙江
Language: 中文, 英语
细胞免疫治疗
实体瘤
临床研究
Car-T治疗
Nk细胞
癌症治疗
免疫治疗
肿瘤学
临床试验
创新疗法
Areas of Focus
- 实体瘤创新细胞免疫治疗
Work Experience
- 2019-12 至今 - 浙江大学医学院附属第一医院 - 主任医师
- 2008-12 至 2019-12 - 浙江大学医学院附属第一医院 - 副主任医师
- 2003-12 至 2008-12 - 浙江大学医学院附属第一医院 - 主治医师
- 1998-09 至 2003-12 - 浙江大学医学院附属第一医院 - 住院医师
Academic Background & Achievements
- 2008-09 至 2013-06 医学博士: 浙江大学医学院
- 2002-09 至 2005-06 医学硕士: 浙江大学医学院
- 1993-09 至 1998-06 医学学士: 浙江医科大学
- 2012 访问学者: 美国印第安纳大学
- 2011 访问学者: 香港大学
Publications
- An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis, Bao X, Wang D, Dai X, Liu C, Zhang H, Jin Y, Tong Z, Li B, Tong C, Xin S, Li X, Wang Y, Liu L, Zhu X, Fu Q, Zheng Y, Deng J, Tian W, Guo T, Zhao P, Chen W, Fang W, 2023
- Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy, Jiawei Shi, Junwei Liu, Xiaoxuan Tu, Bin Li, Zhou Tong, Tian Wang, Yi Zheng, Hongyu Shi, Xun Zeng, Wei Chen, Weiwei Yin, Weijia Fang, 2022
- Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers, Ruyi Zhang, Marco Puzzoni, Stefano Mariani, Yi Zheng, Nicole Liscia, Yixuan Guo, Clelia Donisi, Yu Liu, Valentino Impera, Weijia Fang, Mario Scartozzi, 2021
- Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy, Yizhen Jiang, Xiaoxuan Tu, Xiangying Zhang, Haihong Liao, Shuwen Han, Weiqin Jiang, Yi Zheng, Peng Zhao, Zhou Tong, Qihan Fu, Quan Qi, Junjun Shen, Liping Zhong, Yuefen Pan, Weijia Fang, 2020
- Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy, Xuanwen Bao, Hangyu Zhang, Wei Wu, Shaobing Cheng, Xiaomeng Dai, Xudong Zhu, Qihan Fu, Lulu Liu, Yi Zheng, Peng Zhao, Weijia Fang, Fanglong Liu, 2020
- Ultra-stable biomembrane force probe for accurately determining slow dissociation kinetics of PD-1 blockade antibodies on single living cells, Chenyi An, Wei Hu, Jie Gao, Bing-Feng Ju, Peyman Obeidy, Yunduo, Charles Zhao, Xiaoxuan Tu, Weijia Fang, Lining Arnold Ju, Wei Chen, 2020
- Edge Intelligence: The Confluence of Edge Computing and Artificial Intelligence, Shuiguang Deng, Hailiang Zhao, Weijia Fang, Jianwei Yin, Schahram Dustdar, Albert Y. Zomaya, 2020
- Integrated analysis of single‑cell RNA‑seq and bulk RNA‑seq unravels tumour heterogeneity plus M2‑like tumour‑associated macrophage infiltration and aggressiveness in TNBC, Xuanwen Bao, Run Shi, Tianyu Zhao, Yanfang Wang, Natasa Anastasov, Michael Rosemann, Weijia Fang, 2020
- Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review, Bin Li, Cong Yan, Jiamin Zhu, Xiaobing Chen, Qihan Fu, Hangyu Zhang, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao, Weiqin Jiang, Weijia Fang, 2020
- Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab, Hangyu Zhang, Liyun Yuan, Lulu Liu, Cong Yan, Jinming Cheng, Qihan Fu, Zhou Tong, Weiqin Jiang, Yi Zheng, Peng Zhao, Guoqing Zhang, Weijia Fang, 2020
- Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma, Yi Zheng, Tingting Wang, Xiaoxuan Tu, Yun Huang, Hangyu Zhang, Di Tan, Weiqin Jiang, Shunfeng Cai, Peng Zhao, Ruixue Song, Peilu Li, Nan Qin, Weijia Fang, 2019
- Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients, Zhang H, Liu R, Yan C, Liu L, Tong Z, Jiang W, Yao M, Fang W, Chen Z, 2018
- A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin, Yi Zheng, Xiaoxuan Tu, Peng Zhao, Weiqin Jiang, Lulu Liu, Zhou Tong, Hangyu Zhang, Cong Yan, Weijia Fang, Weilin Wang, 2018
